The global Cyber Knife Market is fueled by the rise in the global cancer population

Global Cyber Knife Market: Overview

Cyberknife is a cutting-edge robotic surgery that treats benign and malignant cancers in difficult-to-reach areas of the human body. The flexible robotic arms handle difficult parts of the body, such as the spine and spinal cord, that are difficult to treat with traditional surgical treatments. The low-risk, painless, and non-invasive surgical procedure uses very precise radiation to eliminate tumours in the body while also delivering regulated radiation to healthy tissues surrounding the tumor-affected area.


According to a study published in the journal Neurosurgery (2017), Cyberknife technology provides trigeminal neurologia patients with long-term pain alleviation.The time it takes to treat a tumour with Cyberknife technology is shorter; nevertheless, this is dependent on the tumor's size, stage, location, and other factors.


The global Cyber Knife Market is fueled by the rise in the global cancer population, the rate of cancer detection and treatment, and medical infrastructure.When compared to alternative radiosurgery possibilities, the Cyberknife technology process is more expensive. As a result, throughout the forecast period, high cost is expected to be a major limitation for the worldwide Cyberknife technology market. Apart from cost, the worldwide Cyber Knife Market is expected to face organisational and regulatory constraints. During the projected period, however, R&D investments and technical advances are expected to open up new opportunities for the worldwide market.


Global Cyberknife Market: Key Segments

Breast cancer, prostate cancer, brain cancer, intracranial cancer, lung cancer, and other cancers are among the applications that the worldwide Cyberknife technology market may be divided into (liver, kidney, etc.). The global market can be divided into hospitals, ambulatory surgery centres, clinics, and others based on end-user.

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the global Cyberknife technology market can be divided. In 2016, 0.25 percent of cancer cases in North America were impacted, and the cancer-affected population is expected to grow by 2.2 percent over the projected period. Nearly 0.46% of the population of Europe was affected with cancer in 2016 and incidence is anticipated to rise by 1.1% during the forecast period. Due to an increase in the number of people affected by cancer, a high rate of cancer diagnosis and treatment, strong medical infrastructure, the availability of medical reimbursements for cancer treatment, the presence of prominent players in North America and Europe, and extensive R&D investments and continuous innovating, North America and Europe are expected to account for a significant share of the Cyberknife technology market.. Because of the huge cancer patient population, rising cancer incidence, and technical improvements, the Cyber Knife Market in Asia Pacific is expected to grow at the quickest rate throughout the forecast period. Latin America and the Middle East and Africa are modest markets, as cost is the most significant obstacle in the industry in these regions.

1) Drivers
  • Increased prevalence of several cancers such as pancreas, liver, lung, prostate, spine, and throat cancer.
  • In industrialised countries, non-invasive and minimally invasive procedures are becoming more popular, as is the use of the cyberknife.
  • Geriatric population is on the rise.
  • Government efforts are becoming more numerous.
2) Restraints
  • Lack of understanding of the cyberknife
  • A scarcity of qualified professionals

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market